American Journal of Roentgenology · 2003 · 74 citations · 31 references
Gadobenate dimeglumine is a capable diagnostic agent for MRI of the breast. Although preliminary, our results suggest that 0.1 mmol/kg of gadobenate dimeglumine may offer advantages over doses of 0.05 and 0.2 mmol/kg of gadobenate dimeglumine and 0.1 mmol/kg of gadopentetate dimeglumine for breast lesion detection and characterization.
31
Robert T. Greenlee, M. B. Hill-Harmon, Thomas S. Murray et al. · CA A Cancer Journal for Clinicians · 2001 · 3.3K citations · Full text
Epidemiology Of Cancer, Health Disparities, Cancer Death +16
Suspicious breast lesions: MR imaging with radiologic-pathologic correlation.
Susan G. Orel, Mitchell D. Schnall, Virginia A. LiVolsi et al. · Radiology · 1994 · 441 citations
Pathophysiologic basis of contrast enhancement in breast tumors
Michael V. Knopp, Hans‐Peter Sinn, J Mattern et al. · Journal of Magnetic Resonance Imaging · 1999 · 405 citations · Full text